Latest news for Sunvault Energy (OTC:SVLT) Stock

Sunvault Energy Inc operates as a provider of electric vehicle (EV) charging equipment and networked EV charging services. Sunvault partners with convenience stores, grocery stores, and residential and commercial real estate landlords to offer EV charging equipment at their premises to enable EV drivers to recharge at those locations.

SUNVAULT ENERGY INC by Sunvault Energy, Inc.

Sunvault Energy Inc

News

Guidance

ACHC

Acadia Healthcare Sees FY24 Adj. EPS $3.45-$3.65 Vs $3.49 Est.; Revenue $3.180B-$3.22B Vs $3.202B Est.

CCRN

Cross Country Healthcare Sees Q3 2024 Adj. EPS $0.08-$0.12 Vs $0.13 Estimate

QIAGEN has updated its FY 2024 outlook based on the solid core business performance in the first half of the year, which was about $15 million CER above guidance, as well as the decision to phase out the NeuMoDx clinical PCR system. As a result, total net sales are expected to be at least $1.985 billion CER and includes a $30 million CER adjustment in expected NeuMoDx sales for 2024.
The outlook for adjusted diluted EPS has been increased to at least $2.16 CER, while the adjusted operating income margin target is for at least 28.5% compared to 26.9% in 2023.

QGEN

Qiagen Sees FY24 EPS $2.16 Vs $2.12 Est.; Revenue $1.985B Vs $2B Est.

Mister Car Wash (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCW#NYSE">MCW</a>) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.09 by 22.22 percent. The company reported quarterly sales of $255.000 million which missed the analyst consensus estimate of $255.331 million by 0.13 percent. This is a 7.64 percent increase over sales of $236.894 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Mister Car Wash Q2 2024 Adj. EPS $0.11 Beats $0.09 Estimate, Sales $255.000M Miss $255.331M Estimate

<ul>
<li>Raises full-year adjusted EBITDA&nbsp;guidance&nbsp;midpoint by&nbsp;$8M.</li>
</ul>

EXAS

Exact Sciences Maintains Full-year 2024 Revenue Guidance Of $2.81B - $2.85B, Est $2.829B

Cross Country Healthcare Sees Q3 2024 Revenue $305M-$315M Vs $334.7M Estimate

Axcelis Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACLS#NASDAQ">ACLS</a>) reported quarterly earnings of $1.55 per share which beat the analyst consensus estimate of $1.35 by 14.81 percent. The company reported quarterly sales of $256.512 million which beat the analyst consensus estimate of $250.302 million by 2.48 percent. This is a 6.37 percent decrease over sales of $273.970 million the same period last year.

ACLS

Axcelis Technologies Q2 2024 GAAP EPS $1.55 Beats $1.35 Estimate, Sales $256.512M Beat $250.302M Estimate

EVTC

Evertec Sees FY24 Revenue $846M-$854M vs $850.49M Est., Adj. EPS $2.98-$3.07 vs $2.90 Est.

Cross Country Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCRN#NASDAQ">CCRN</a>) reported quarterly earnings of $0.10 per share which missed the analyst consensus estimate of $0.13 by 23.08 percent. The company reported quarterly sales of $339.77 million which beat the analyst consensus estimate of $334.76 million by 1.50 percent. This is a 37.16 percent decrease over sales of $540.70 million the same period last year.

Cross Country Healthcare Q2 2024 Adj EPS $0.10 Misses $0.13 Estimate, Sales $339.77M Beat $334.76M Estimate

JAZZ

Jazz Pharmaceuticals Sees FY24 Adj EPS $19.20-$20.30 Vs $18.51 Est.; Revenue $4.0B-$4.1B Vs $4.047B Est.

2024 Revenue Guidance
The company expects 2024 net sales to be in the range of $370 million to $376 million based on the latest foreign currency exchange rates.

GKOS

Glaukos Sees FY24 Revenue $370M-$376M Vs $363.02M Est.

Kilroy Realty Corporation Updates 2024 Nareit-Defined FFO Guidance to $4.21-$4.31 Per Share; Midpoint Now $4.26; Raises Net Income Guidance to $1.50-$1.59 Per Share; Adjusts Key Assumptions for NOI, Occupancy, and Development Spending

Outlook
The company is updating its previously provided guidance for fiscal 2024:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Previous 2024 Guidance</td>
<td colspan="1" rowspan="1">Updated 2024 Guidance</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Revenues</td>
<td colspan="1" rowspan="1">$1.690 billion</td>
<td colspan="1" rowspan="1">$1.700 billion</td>
</tr>
<tr>
<td colspan="1" rowspan="1">GAAP Net Income</td>
<td colspan="1" rowspan="1">$495 million</td>
<td colspan="1" rowspan="1">$500 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">GAAP EPS</td>
<td colspan="1" rowspan="1">$19.70</td>
<td colspan="1" rowspan="1">$19.90</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Non-GAAP Net Income</td>
<td colspan="1" rowspan="1">$573 million</td>
<td colspan="1" rowspan="1">$582 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Non-GAAP EPS</td>
<td colspan="1" rowspan="1">$22.80</td>
<td colspan="1" rowspan="1">$23.16</td>
</tr>
</tbody>
</table>
</figure>
The Non-GAAP financial measures are described in the financial table captioned "Reconciliation of Non-GAAP Guidance."

FICO

FICO Sees FY24 Revenue $1.69B-$1.7B Vs $1.707B Estimate; Sees Adj. EPS $22.80-$23.16 Vs $23.63 Estimate

Evertec (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVTC#NYSE">EVTC</a>) reported quarterly earnings of $0.83 per share which beat the analyst consensus estimate of $0.69 by 20.29 percent. The company reported quarterly sales of $212.000 million which beat the analyst consensus estimate of $211.103 million by 0.43 percent. This is a 26.89 percent increase over sales of $167.076 million the same period last year.

Evertec Q2 2024 Adj. EPS $0.83 Beats $0.69 Estimate, Sales $212.000M Beat $211.103M Estimate

The company is reducing its Specialties adjusted EBITDA&nbsp;outlook&nbsp;due to a slower than expected market rebound and higher logistics costs related to the ongoing conflict in the&nbsp;Middle East.&nbsp;
As a result of cost actions&nbsp;, Albemarle expects to recognize a charge in the range of&nbsp;$0.9-$1.1 billion&nbsp;as an exceptional item in the company&#39;s&nbsp;third-quarter&nbsp;2024 results.

Albemarle Maintains Its Prior Full-year Outlook Considerations, Which Are Based On Observed Lithium Market Price Scenarios

2024 Financial Outlook TransMedics is raising&nbsp;its full year 2024 revenue guidance to be in the range of $425 million to $445 million, which represents 76% to 84% growth compared to the company's prior year revenue. TransMedics' prior 2024 revenue guidance was $390 million to $400 million.

TMDX

TransMedics Group Raises FY24 Revenue Guidance From $390M-$400M To $425M-$445M Vs $401.43M	Est.

ALXO

Trading Halt: Halt status updated at 4:25:00 PM ET: Quotation Resumption: News and Resumption Times

Kilroy Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRC#NYSE">KRC</a>) reported quarterly earnings of $1.10 per share which beat the analyst consensus estimate of $1.08 by 1.85 percent. The company reported quarterly sales of $275.92 million which missed the analyst consensus estimate of $277.28 million by 0.49 percent. This is a 1.92 percent decrease over sales of $281.31 million the same period last year.

Kilroy Realty Q2 2024 FFO $1.10 Beats $1.08 Estimate, Sales $275.92M Miss $277.28M Estimate

Antero Midstream (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AM#NYSE">AM</a>) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.22 by 4.55 percent. The company reported quarterly sales of $269.795 million which missed the analyst consensus estimate of $269.801 million by 0 percent. This is a 4.46 percent increase over sales of $258.287 million the same period last year.

Antero Midstream Q2 2024 Adj. EPS $0.23 Beats $0.22 Estimate, Sales $269.795M Miss $269.801M Estimate

Arm Holdings Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) shares are trading lower after the company reported its first-quarter financial results Wednesday. Here's a look at the <a href="https://www.benzinga.com/pressreleases/24/07/b40080645/arm-holdings-plc-reports-results-for-the-first-quarter-of-the-financial-year-ended-2025">details from the report.</a> 
The Details: Arm reported quarterly earnings of 40 cents per share, which beat the analyst consensus estimate of 34 cents by 17.65%. Quarterly sales clocked in at $939 million, which beat the analyst consensus estimate of $902.691 million by 4.02% with record license revenue and strong growth in royalty revenue.
The company reported license and other revenue of $472 million, up 72% year-over-year, due to the signing of multiple high-value license agreements. Royalty revenue came in at $467 million, up 17% year-over-year, driven by the rapidly increasing penetration of Armv9-based chips and strong growth in premium smartphones.
Arm said it saw strong non-GAAP operating income growth to $448 million resulting in a 47.7% non-GAAP operating margin.
Read Also: <a href="https://www.benzinga.com/news/earnings/24/07/40076709/whats-going-on-with-sofi-stock-after-earnings">What&#8217;s Going On With SoFi Stock After Earnings?</a> 
&#8220;AI demand and rising CSS adoption across major market segments drove record revenue,&#8221; said Rene Haas, CEO of Arm Holdings. &#8220;As the energy needs of AI continue to escalate, so does the demand for the high-performance, power-efficient Arm compute platform.&#8221;
Outlook: Arm Holdings sees second-quarter revenue in a range of $780 million to $830 million, versus the $804.08 million estimate, and earnings of between 23 cents and 27 cents, versus the 27-cent estimate.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="&#x1f534;WATCH LIVE: ARM Q1 2024 Earnings Call &#x7C; $ARM" width="500" height="281" src="https://www.youtube.com/embed/DpVCmvwEbw0?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
ARM Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Arm Holdings shares are down 9.41% after-hours at $130.60 after gaining more than 8% in regular trading Wednesday. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/40022763/lattice-semiconductor-stock-falls-on-worse-than-expected-q2-results">Lattice Semiconductor Stock Falls On Worse-Than-Expected Q2 Results</a></li>
</ul>
Image: Courtesy of Arm Holdings Plc

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

Sunvault Energy

News

Latest news for Sunvault Energy (OTC:SVLT) Stock